NBRV
Geode Capital Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-42,738
| Closed | -$7K | – | 5112 |
|
|
2022
Q2 | $7K | Hold |
42,738
| – | – | ﹤0.01% | 4999 |
|
|
2022
Q1 | $17K | Hold |
42,738
| – | – | ﹤0.01% | 4937 |
|
|
2021
Q4 | $25K | Hold |
42,738
| – | – | ﹤0.01% | 4932 |
|
|
2021
Q3 | $50K | Buy |
42,738
+21,672
| +103% | +$25.4K | ﹤0.01% | 4781 |
|
|
2021
Q2 | $28K | Buy |
21,066
+7,841
| +59% | +$10.4K | ﹤0.01% | 4699 |
|
|
2021
Q1 | $21K | Buy |
+13,225
| New | +$21K | ﹤0.01% | 4444 |
|
|
2020
Q4 | – | Sell |
-62,669
| Closed | -$33K | – | 4330 |
|
|
2020
Q3 | $33K | Hold |
62,669
| – | – | ﹤0.01% | 4079 |
|
|
2020
Q2 | $42K | Hold |
62,669
| – | – | ﹤0.01% | 4002 |
|
|
2020
Q1 | $36K | Hold |
62,669
| – | – | ﹤0.01% | 3974 |
|
|
2019
Q4 | $82K | Hold |
62,669
| – | – | ﹤0.01% | 4010 |
|
|
2019
Q3 | $125K | Hold |
62,669
| – | – | ﹤0.01% | 3896 |
|
|
2019
Q2 | $152K | Buy |
62,669
+15,930
| +34% | +$38.6K | ﹤0.01% | 3857 |
|
|
2019
Q1 | $114K | Hold |
46,739
| – | – | ﹤0.01% | 3870 |
|
|
2018
Q4 | $68K | Hold |
46,739
| – | – | ﹤0.01% | 3938 |
|
|
2018
Q3 | $126K | Hold |
46,739
| – | – | ﹤0.01% | 3883 |
|
|
2018
Q2 | $162K | Buy |
46,739
+34,650
| +287% | +$120K | ﹤0.01% | 3776 |
|
|
2018
Q1 | $60K | Hold |
12,089
| – | – | ﹤0.01% | 3928 |
|
|
2017
Q4 | $72K | Hold |
12,089
| – | – | ﹤0.01% | 3878 |
|
|
2017
Q3 | $99K | Buy |
+12,089
| New | +$99K | ﹤0.01% | 3828 |
|
|
2017
Q2 | – | Sell |
-11,593
| Closed | -$139K | – | 4129 |
|
|
2017
Q1 | $139K | Buy |
+11,593
| New | +$139K | ﹤0.01% | 3756 |
|